tolafentrine has been researched along with pentoxifylline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghofrani, HA; Grimminger, F; Krupnik, E; Rose, F; Schermuly, RT; Schudt, C; Seeger, W; Tenor, H; Walmrath, D; Weissmann, N | 1 |
Hareng, L; Hartung, T; Meergans, T; Volk, HD; von Aulock, S | 1 |
2 other study(ies) available for tolafentrine and pentoxifylline
Article | Year |
---|---|
Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aerosols; Animals; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Iloprost; Naphthyridines; Pentoxifylline; Phosphodiesterase Inhibitors; Rabbits; Vasodilation; Vasodilator Agents | 2001 |
Cyclic AMP increases endogenous granulocyte colony-stimulating factor formation in monocytes and THP-1 macrophages despite attenuated TNF-alpha formation.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Bucladesine; Cell Line; Colforsin; Cyclic AMP; Dinoprostone; Female; Granulocyte Colony-Stimulating Factor; Humans; In Vitro Techniques; Lipopolysaccharides; Macrophages; Monocytes; Naphthyridines; Pentoxifylline; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Tumor Necrosis Factor-alpha; Up-Regulation | 2003 |